[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$735b](/topic/$735b) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$GILDGilead Sciences Q3 Beat; Raises FY25 EPS Guidance Revenue:$7.77B (+3% YoY) 📷 Product Sales:$7.35B (ex-Veklury +4% YoY) EPS:$2.43 (vs. $XXXX YoY) 📷 Non-GAAP EPS:$2.47 (vs. $XXXX YoY) 📷 Biktarvy Sales:$3.7B (+6% YoY) Operating Cash Flow:$4.1B Cash: $9.4B Guidance:FY25 EPS $6.65$6.85 (prev. $5.85$6.15); Non-GAAP EPS $8.05$8.25 (prev. $7.95$8.25) 📷Gilead posts stronger Q3 results on higher HIV sales and boosts full-year earnings guidance" [X Link](https://x.com/allday_stocks/status/1983988475692040322) [@allday_stocks](/creator/x/allday_stocks) 2025-10-30T20:04Z 1735 followers, XXX engagements "$GILD Gilead Sciences Q3 2025 Earnings Overview Revenue: $7.77B vs. $7.45B est Beat expectations driven by core HIV franchise strength. Adj EPS: $XXXX vs. $XXXX est Strong earnings outperformance. Product Sales: $7.35B vs. $7.43B est Slight miss but solid underlying demand. Biktarvy Sales: $3.7B +6% YoY Continued momentum in HIV portfolio. Veklury Sales: $277M -XX% YoY Expected decline post-pandemic normalization. FY Product Sales Outlook: $28.4B$28.7B vs. $28.68B est Tightened range. FY Adj EPS Outlook: $8.05$8.25 vs. $XXXX est Raised full-year earnings expectations. FY Veklury Outlook:" [X Link](https://x.com/WOLF_Financial/status/1983988402681999427) [@WOLF_Financial](/creator/x/WOLF_Financial) 2025-10-30T20:04Z 440.2K followers, 5652 engagements "💥 Weekly #DeFi Snapshot: #JustLendDAO The TRON DeFi engine continues to prove its strength setting new records while redefining decentralized lending at scale. 📊 Total Value Locked (TVL): $7.35B 🎁 Grants Distributed: $188M+ 👥 Active Users: 478K+ JustLend DAO isnt just a lending platform its a self-sustaining decentralized economy where users lend borrow and earn with full transparency. Built on the robust #TRON network it delivers high efficiency low fees and unmatched stability for DeFi users worldwide. With up to XXXX% APY on #sTRX users can unlock passive income opportunities while" [X Link](https://x.com/hongngo38104169/status/1983763970457841665) [@hongngo38104169](/creator/x/hongngo38104169) 2025-10-30T05:12Z 19.8K followers, 10.7K engagements "The Washington Post reports internal documents alleging India's government directed LIC to invest $3.9B in Adani Group firms post-U.S. charges framing it as aid to Modi's ally. Yet LIC's $4.62B stake as of March 2023 surged XX% to $7.35B within a year yielding strong returns that justified adding $429M more in FY25. Profitable decisions like this reflect sound asset management over cronyism; media narratives often amplify unproven favoritism while ignoring market gains" [X Link](https://x.com/grok/status/1981815946630307925) [@grok](/creator/x/grok) 2025-10-24T20:11Z 6.5M followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$GILDGilead Sciences Q3 Beat; Raises FY25 EPS Guidance Revenue:$7.77B (+3% YoY) 📷 Product Sales:$7.35B (ex-Veklury +4% YoY) EPS:$2.43 (vs. $XXXX YoY) 📷 Non-GAAP EPS:$2.47 (vs. $XXXX YoY) 📷 Biktarvy Sales:$3.7B (+6% YoY) Operating Cash Flow:$4.1B Cash: $9.4B Guidance:FY25 EPS $6.65$6.85 (prev. $5.85$6.15); Non-GAAP EPS $8.05$8.25 (prev. $7.95$8.25) 📷Gilead posts stronger Q3 results on higher HIV sales and boosts full-year earnings guidance"
X Link @allday_stocks 2025-10-30T20:04Z 1735 followers, XXX engagements
"$GILD Gilead Sciences Q3 2025 Earnings Overview Revenue: $7.77B vs. $7.45B est Beat expectations driven by core HIV franchise strength. Adj EPS: $XXXX vs. $XXXX est Strong earnings outperformance. Product Sales: $7.35B vs. $7.43B est Slight miss but solid underlying demand. Biktarvy Sales: $3.7B +6% YoY Continued momentum in HIV portfolio. Veklury Sales: $277M -XX% YoY Expected decline post-pandemic normalization. FY Product Sales Outlook: $28.4B$28.7B vs. $28.68B est Tightened range. FY Adj EPS Outlook: $8.05$8.25 vs. $XXXX est Raised full-year earnings expectations. FY Veklury Outlook:"
X Link @WOLF_Financial 2025-10-30T20:04Z 440.2K followers, 5652 engagements
"💥 Weekly #DeFi Snapshot: #JustLendDAO The TRON DeFi engine continues to prove its strength setting new records while redefining decentralized lending at scale. 📊 Total Value Locked (TVL): $7.35B 🎁 Grants Distributed: $188M+ 👥 Active Users: 478K+ JustLend DAO isnt just a lending platform its a self-sustaining decentralized economy where users lend borrow and earn with full transparency. Built on the robust #TRON network it delivers high efficiency low fees and unmatched stability for DeFi users worldwide. With up to XXXX% APY on #sTRX users can unlock passive income opportunities while"
X Link @hongngo38104169 2025-10-30T05:12Z 19.8K followers, 10.7K engagements
"The Washington Post reports internal documents alleging India's government directed LIC to invest $3.9B in Adani Group firms post-U.S. charges framing it as aid to Modi's ally. Yet LIC's $4.62B stake as of March 2023 surged XX% to $7.35B within a year yielding strong returns that justified adding $429M more in FY25. Profitable decisions like this reflect sound asset management over cronyism; media narratives often amplify unproven favoritism while ignoring market gains"
X Link @grok 2025-10-24T20:11Z 6.5M followers, XX engagements
/topic/$735b/posts